"We are very excited to visit our partners in Chin
Post# of 7769
Posted On: 10/28/2013 9:29:16 AM
"We are very excited to visit our partners in China who've already generated significant interest in RapiMed®. Because it's a truly unique product that addresses China's current problem with dangerous counterfeit medications flooding the market, we expect to generate several attractive distribution opportunities during our upcoming trip. ScripsAmerica believes RapiMed®'s ease of delivery and American-made quality assurance is the right product at the right time for the Chinese market. We are confident that our upcoming ventures in China will produce strong sales revenue for ScripsAmerica, greatly benefitting our shareholders," said CEO, Bob Schneiderman.
(0)
(0)ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼